Previous studies have also shown that global hydroxymethylation may be impaired during MS due to reduced expression of TET2 [37], and that the reduction in hydroxymethylation and TET levels in the spinal cord is associated with the induction of EAE in a mouse model [38]. Here, TET2 is linked to myeloid sarcoma.